We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+12.58%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$24B
AUM Growth
+$1.56B
(+6.9%)
Cap. Flow
-$931M
Cap. Flow
% of AUM
-3.87%
Top 10 Holdings %
Top 10 Hldgs %
25.33%
Holding
2,059
New
128
Increased
454
Reduced
915
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$36.7M |
| 2 |
VICI Properties
VICI
|
+$32.5M |
| 3 |
Elevance Health
ELV
|
+$27.3M |
| 4 |
Arch Capital
ACGL
|
+$24.7M |
| 5 |
Kite Realty
KRG
|
+$24.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$55.4M |
| 2 |
Apple
AAPL
|
+$48.9M |
| 3 |
Synopsys
SNPS
|
+$44.7M |
| 4 |
Netflix
NFLX
|
+$40.2M |
| 5 |
Markel Group
MKL
|
+$35.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.86% |
| 2 | Financials | 12.81% |
| 3 | Healthcare | 12.06% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Prestige Consumer Healthcare
PBH
$2.35B
| $128K | ﹤0.01% |
2,100
-14,400
| -87% | -$855K |
|
|
BRKL
1652
DELISTED
Brookline Bancorp
BRKL
| $127K | ﹤0.01% |
11,700
| – | – |
|
1653
Zevra Therapeutics
ZVRA
$563M
| $127K | ﹤0.01% |
19,400
+11,700
| +152% | +$54.7K |
|
1654
Genworth Financial
GNW
$3.8B
| $126K | ﹤0.01% |
19,000
+3,900
| +26% | +$23.7K |
|
1655
Forestar Group
FOR
$1.44B
| $122K | ﹤0.01% |
3,700
-400
| -10% | -$11.6K |
|
1656
Titan International
TWI
$516M
| $122K | ﹤0.01% |
8,200
-5,900
| -42% | -$77.7K |
|
1657
ABM Industries
ABM
$2.8B
| $121K | ﹤0.01% |
2,700
-23,700
| -90% | -$1M |
|
1658
Fastly Inc
FSLY
$3.17B
| $121K | ﹤0.01% |
6,800
+3,400
| +100% | +$57.4K |
|
|
WSR
1659
DELISTED
Whitestone REIT
WSR
| $120K | ﹤0.01% |
9,800
| – | – |
|
|
RAIN
1660
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $120K | ﹤0.01% |
100,100
| – | – |
|
|
HI
1661
DELISTED
Hillenbrand
HI
| $119K | ﹤0.01% |
2,500
-600
| -19% | -$24.6K |
|
1662
LivaNova
LIVN
$4.3B
| $119K | ﹤0.01% |
2,300
-7,600
| -77% | -$368K |
|
|
SFBS
1663
ServisFirst Bancshares
SFBS
$4.79B
| $119K | ﹤0.01% |
1,800
+500
| +38% | +$27K |
|
|
ITOS
1664
DELISTED
iTeos Therapeutics
ITOS
| $118K | ﹤0.01% |
10,800
-4,300
| -28% | -$42.6K |
|
1665
Korn Ferry
KFY
$3.98B
| $118K | ﹤0.01% |
2,000
-2,000
| -50% | -$102K |
|
|
GOOD
1666
Gladstone Commercial Corp
GOOD
$627M
| $116K | ﹤0.01% |
8,800
| – | – |
|
1667
NeoGenomics
NEO
$1.81B
| $116K | ﹤0.01% |
7,200
| – | – |
|
1668
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $116K | ﹤0.01% |
245
-60
| -20% | -$26.7K |
|
|
UHT
1669
Universal Health Realty Income Trust
UHT
$608M
| $116K | ﹤0.01% |
2,700
| – | – |
|
1670
Urban One Class A
UONE
$23.3M
| $116K | ﹤0.01% |
2,880
| – | – |
|
1671
First Bancorp
FNLC
$394M
| $115K | ﹤0.01% |
4,100
| – | – |
|
1672
Liquidia Corp
LQDA
$7.67B
| $115K | ﹤0.01% |
9,600
-70,400
| -88% | -$507K |
|
1673
Paysign
PAYS
$486M
| $115K | ﹤0.01% |
41,200
-93,800
| -69% | -$206K |
|
1674
Apogee Therapeutics
APGE
$10.2B
| $114K | ﹤0.01% |
4,100
| – | – |
|
1675
Ziff Davis
ZD
$1.9B
| $114K | ﹤0.01% |
1,700
-700
| -29% | -$44.4K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q4 2023 Portfolio in Review
As of Q4 2023, STRS Ohio held 2,059 positions worth $24B, up 6.9% from $22.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
STRS Ohio withdrew a net $931M in Q4 2023, closing 153 positions and reducing 915 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $55.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
Against the trend, STRS Ohio opened a new position in Synovus worth $16.4M.
- STRS Ohio's largest Q4 2023 buy was Synovus: 436,000 shares worth $16.4M.
- STRS Ohio added most to Broadcom in Q4 2023, an estimated $36.7M increase.
- STRS Ohio's biggest Q4 2023 reduction was Apple, cutting an estimated $48.9M.
- STRS Ohio fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $55.4M.
- STRS Ohio's ten largest holdings make up 25% of its $24B portfolio in Q4 2023.
- STRS Ohio opened 128 new positions and closed 153 in Q4 2023.
- STRS Ohio's portfolio value rose 6.9% quarter-over-quarter to $24B.
Based on STRS Ohio's 13F filing for Q4 2023, filed 30 Jan 2024.